Search Results - Anjuli May Jaen

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Immunogenicity and safety of boosting with a recombinant two-component SARS-CoV-2 vaccine: two randomized, parallel-controlled, phase 2 studies

    Immunogenicity and safety of boosting with a recombinant two-component SARS-CoV-2 vaccine: two randomized, parallel-controlled, phase 2 studies by Abundio Balgos, Suad Hannawi, Wen-Li Chen, Alaa Abuquta, Linda Safeldin, Aala Hassan, Ahmad Alamadi, Louie Tirador, Anjuli May Jaen, Ralph Elvi Villalobos, Chen Mo, Zi-Jing Yue, Ying Ma, Qing-Shuang Wang, Ren-Du Wen, Zheng Yao, Jia-Ping Yu, Wen-Rong Yao, Jian-Hui Zhang, Kun-Xue Hong, Yong Liu, Jing-Xin Li

    Published 2024-12-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Safety and immunogenicity of UB-612 heterologous booster in adults primed with mRNA, adenovirus, or inactivated COVID-19 vaccines: a randomized, active-controlled, Phase 3 trialResearch in context

    Safety and immunogenicity of UB-612 heterologous booster in adults primed with mRNA, adenovirus, or inactivated COVID-19 vaccines: a randomized, active-controlled, Phase 3 trialRes... by Alexander Rumyantsev, Lixia Wang, Shixia Wang, Tracy Kemp, Alana Wriggins, Amy Burks, Danielle Fisher, Katie Brokke, Amy Fix, Susan Hensley, Maggie Lewis, Ray Zhu, Kate Wang, Carolyn Shasha, Giulia Piccini, Alessandro Manenti, Emanuele Montomoli, Rodrigo DeAntonio, Xavier Saez-Llorens, Milagros Chan, Edison Alberto, Ma Dovie Lallaine Borra, Anjuli May Jaen, Gray Heppner, Ulo Palm, Thomas P. Monath

    Published 2025-08-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: